Position in LYEL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,901
+$12,763 QoQ
Shares Held
693
+1773.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SIMPLEX TRADING, LLC holds $73,356,830 across 197 Biotechnology names. LYEL ranks #149 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
219,573 | $11,154,308 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
77,808 | $6,549,099 | |
| 3 | ERAS |
Erasca, Inc.
|
252,747 | $4,089,446 | |
| 4 | QURE |
uniQure N.V.
|
231,769 | $3,789,423 | |
| 5 | QNCX |
Quince Therapeutics, Inc.
|
154,093 | $3,112,678 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
41,434 | $3,076,888 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
69,515 | $2,802,149 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
88,035 | $2,438,569 |
All Filings in LYEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,901 | 693 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,138 | 37 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,630 | 162 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,634 | 298 | Shares | Sole | 2025-08-05 | |
| No filing history on record for this holder in this stock. | ||||||